Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.
Other Duke Prostate Center research has found that inflammation in tumors is associated with recurrent prostate cancer, so these two findings, taken together, provide more impetus for considering the use of statins to possibly control or prevent prostate cancer
The researchers presented their finding at the American Urological Association’s annual meeting on April 26, 2009.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...